# FDA Inspection 1246916 - Lek Pharmaceuticals - July 26, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/lek-pharmaceuticals/14403f78-726e-43ae-ae4d-9fea93cbc5d0
Source feed: FDA_Inspections

> FDA Inspection 1246916 for Lek Pharmaceuticals on July 26, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246916
- Company Name: Lek Pharmaceuticals
- Inspection Date: 2024-07-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1254088 - 2023-12-11](https://www.globalkeysolutions.net/records/fda_inspections/lek-pharmaceuticals/ab9d79b7-fdee-4f50-a6cc-d5b1524e93cc)
- [FDA Inspection 1178973 - 2022-03-18](https://www.globalkeysolutions.net/records/fda_inspections/lek-pharmaceuticals/45b6f40d-76b3-4a3a-ba54-df7addeaffc4)
- [FDA Inspection 1005712 - 2017-02-24](https://www.globalkeysolutions.net/records/fda_inspections/lek-pharmaceuticals/3f47bec3-1e28-4c3e-8f8d-926d581862c3)
- [FDA Inspection 935159 - 2015-06-30](https://www.globalkeysolutions.net/records/fda_inspections/lek-pharmaceuticals/0a8fc7e3-f9f4-434f-878a-68b96987e873)
- [FDA Inspection 848663 - 2013-09-13](https://www.globalkeysolutions.net/records/fda_inspections/lek-pharmaceuticals/bf8c3cd0-5aa0-4127-94dd-7b5d70d68f4a)

Company: https://www.globalkeysolutions.net/companies/lek-pharmaceuticals/6b651b9c-9e4f-46ac-a02a-ddc22f9bc3a6

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c